The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Medical Progress
PreviousPrevious
Volume 341:815-826 September 9, 1999 Number 11
NextNext

Anthrax
Terry C. Dixon, B.S., Matthew Meselson, Ph.D., Jeanne Guillemin, Ph.D., and Philip C. Hanna, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Anthrax is an often fatal bacterial infection that occurs when Bacillus anthracis endospores enter the body through abrasions in the skin or by inhalation or ingestion.1 It is a zoonosis to which most mammals, especially grazing herbivores, are considered susceptible. Human infections result from contact with contaminated animals or animal products, and there are no known cases of human-to-human transmission. Human anthrax is not common, and only one of us has seen a case. Cutaneous anthrax, the most common form, is usually curable. A small percentage of cutaneous infections become systemic, and these can be fatal. Systemic infection resulting from . . . [Full Text of this Article]

Pathogenesis

Clinical Manifestations

Cutaneous Anthrax

Gastrointestinal and Oropharyngeal Anthrax

Inhalational Anthrax

Anthrax Meningitis

Diagnosis

Differential Diagnosis

Bacteriologic Tests

Serologic and Immunologic Tests

New Molecular Diagnostic Methods

Prevention and Treatment

Prophylaxis, Vaccination, and Decontamination

Treatment

            Antibiotics

            Potential New Treatments

Future Challenges


Source Information

From the Department of Microbiology, Duke University Medical Center, Durham, N.C. (T.C.D., P.C.H.); the Department of Molecular and Cellular Biology, Harvard University, Cambridge, Mass. (M.M.); the Department of Sociology, Boston College, Chestnut Hill, Mass. (J.G.); and the Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor (P.C.H.).

Address reprint requests to Dr. Hanna at 1150 W Medical, 5641 MS II, Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48104, or at dixont@umich.edu.

References


Related Letters:

Anthrax
Furmanski M., Hanna P. C., Dixon T. C.
Extract | Full Text  
N Engl J Med 2000; 342:61-62, Jan 6, 2000. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.